Jobe Jared B, Adams Alexandra K, Henderson Jeffrey A, Karanja Njeri, Lee Elisa T, Walters Karina L
Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
J Prim Prev. 2012 Aug;33(4):153-9. doi: 10.1007/s10935-012-0277-9.
American Indian and Alaska Native (AI/AN) populations bear a heavy burden of cardiovascular disease (CVD), and they have the highest rates of risk factors for CVD, such as cigarette smoking, obesity, and diabetes, of any U.S. population group. Yet, few randomized controlled trials have been launched to test potential preventive interventions in Indian Country. Five randomized controlled trials were initiated recently in AI/AN communities to test the effectiveness of interventions targeting adults and/or children to promote healthy behaviors that are known to impact biological CVD risk factors. This article provides a context for and an overview of these five trials. The high burden of CVD among AI/AN populations will worsen unless behaviors and lifestyles affecting CVD risk can be modified. These five trials, if successful, represent a starting point in addressing these significant health disparities.
美国印第安人和阿拉斯加原住民(AI/AN)群体承受着心血管疾病(CVD)的沉重负担,而且在所有美国人群体中,他们患CVD风险因素的比例最高,如吸烟、肥胖和糖尿病。然而,在印第安地区开展的用于测试潜在预防干预措施的随机对照试验却很少。最近在AI/AN社区启动了五项随机对照试验,以测试针对成人和/或儿童的干预措施的有效性,这些干预措施旨在促进已知会影响CVD生物风险因素的健康行为。本文为这五项试验提供了背景信息并进行了概述。除非能够改变影响CVD风险的行为和生活方式,否则AI/AN人群中CVD的高负担将会加剧。如果这五项试验取得成功,将成为解决这些重大健康差距问题的一个起点。